Abstract
To the Editor: Acute radiation dermatitis (RD) is among the most common adverse events of radiation therapy (RT), affecting as many as 95% of patients undergoing treatment.1 Typically, RD causes hyperpigmentation and erythema in the first 1 to 2 weeks of treatment, followed by dry and moist desquamation 3 to 4 weeks into RT.1 Although prior studies have examined the effect of prescribed topical treatments for RD on quality of life (QoL),2 little is known about how radiation-induced skin toxicity can affect patients' QoL in general throughout the treatment course.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
